KDM5A and breast carcinoma: In PIK3CAH1047R-mutated breast cancer, the phosphorylation of KDM5A by the overactivated AKT blocks its translocation to the nucleus, which limits the access of KDM5A to its substrates, H3K4me2 and H3K4me3.